Package 50332-0139-3

Brand: aspirin

Generic: aspirin
NDC Package

Package Facts

Identity

Package NDC 50332-0139-3
Digits Only 5033201393
Product NDC 50332-0139
Description

25 PACKET in 1 BOX, UNIT-DOSE (50332-0139-3) / 2 TABLET in 1 PACKET

Marketing

Marketing Status
Marketed Since 2023-01-01
Brand aspirin
Generic aspirin
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "356da65e-7683-4116-aaef-a4c8decd1297", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "unii": ["R16CO5Y76E"], "rxcui": ["212033"], "spl_set_id": ["a1c73edf-861d-478b-9d3c-0eddcc6879cc"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["HART Health"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 PACKET in 1 BOX, UNIT-DOSE (50332-0139-3)  / 2 TABLET in 1 PACKET", "package_ndc": "50332-0139-3", "marketing_start_date": "20230101"}, {"sample": false, "description": "50 PACKET in 1 BOX, UNIT-DOSE (50332-0139-4)  / 2 TABLET in 1 PACKET", "package_ndc": "50332-0139-4", "marketing_start_date": "20230101"}, {"sample": false, "description": "125 PACKET in 1 BOX, UNIT-DOSE (50332-0139-7)  / 2 TABLET in 1 PACKET", "package_ndc": "50332-0139-7", "marketing_start_date": "20230101"}, {"sample": false, "description": "250 PACKET in 1 BOX, UNIT-DOSE (50332-0139-8)  / 2 TABLET in 1 PACKET", "package_ndc": "50332-0139-8", "marketing_start_date": "20230101"}], "brand_name": "ASPIRIN", "product_id": "50332-0139_356da65e-7683-4116-aaef-a4c8decd1297", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "50332-0139", "generic_name": "ASPIRIN", "labeler_name": "HART Health", "product_type": "HUMAN OTC DRUG", "brand_name_base": "ASPIRIN", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "M", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20230101", "listing_expiration_date": "20271231"}